ClinicalTrials.gg
RecruitingNCT04119180Updated Dec 10, 2024

Sedation Versus Protective Stabilization for Pediatric Dental Treatment

A Phase 4 interventional study of Ketamine 50 MG/ML and Midazolam Hcl 2Mg/Ml Syrup in Child Behavior and Dental Caries in Children, sponsored by Universidade Federal de Goias. Recruiting at 2 sites in Brazil. Open to participants aged 1 Year to 7 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-10.

Sponsored by Universidade Federal de Goias · Phase 4, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Feb 2025, 1 year 8 months ago, but the record still lists the study as recruiting.
  • Started Jan 2020; still recruiting 6 years 9 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Phase 4
Study type
Interventional
Enrollment
152
Allocation
Non-randomized
Ages
1 Year to 7 Years
Sex
All
01

Study summary

There is a lack of evidence on the effectiveness of moderate sedation in pediatric dentistry, compared to protective stabilization, which remains routinely used in the Brazilian context despite moral questions. The objective of this prospective nonrandomized clinical trial is to evaluate the effectiveness of the use of moderate sedation, compared to the protective stabilization, in the dental care of children with fear / anxiety and / or dental behavior problem, and associated factors. The study will be carried out in outpatient clinics of the Dental Schools of the Federal University of Goiás (UFG) and University of São Paulo (USP), with the support of professors from King's College London through the partnership CEDACORE - Children Experiencing Dental Anxiety: Collaboration on Research and Education. Participants will be 152 children under 7 years of age with dental caries, who need specialized dental treatment due to a history of non-cooperation with dental care. The interventions to be compared are moderate sedation with oral administration of ketamine and midazolam (UFG) and protective stabilization (USP). The primary endpoint 'behavior / anxiety of the child during treatment will be assessed using the Ohio State University Behavioral Rating Scale. The secondary outcomes are: dental behavioral and anxiety evolution of the child, child' pain during procedure, impact on the quality of life related to oral health, parents and dentists' satisfaction and stress, adverse events for sedated participants, longevity of composite and glass ionomer cement restorations, chronotype and physiological stress of these children. A cost-efficacy analysis will be produced at the end of the study from the perspective of the Sistema Único de Saúde. Additionally, at the end of 36 months, the investigators expect to contribute to the identification of psychosocial aspects related to dental behavior problems in children in early childhood. It is important to highlight the perspective of technological innovation, with the creation of a digital platform that will allow the registration of data related to the dental care of children worldwide and favor analyzes in the methodology of data science.

02

Conditions studied

  • Child Behavior
  • Dental Caries in Children

Keywords

  • Dental Anxiety
  • Dental Caries
  • Conscious Sedation
  • Physical Restraint
  • Cost-Efficacy Analysis
03

In context

Child Behavior

224 studies on the registry are indexed under Child Behavior; 39 are open to participants now.

This study's planned enrollment of 152 is close to the median of 140 across 197 interventional studies indexed under Child Behavior.

Browse Child Behavior studies →

Lead sponsor

Universidade Federal de Goias is the lead sponsor of 42 studies on the registry; 3 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
1 Year to 7 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Children presenting cavities that need dental restoration
  • (healthy) or II (mild and controlled systemic disease - persistent asthma, for example) children (ASA, 2015)
  • Medical history without neurological or cognitive impairment
  • Children who do not use medicines that may impair cognitive functions
  • Children at low risk for airway obstruction (Mallampati less than 2 and / or tonsil hypertrophy occupying less than 50% of the oropharynx) (Mallampati et al., 1985)

Exclusion criteria

Exclusion Criteria:

  • Children with positive or definitely positive behavior (Frankl et al. 1962) in the dental examination session
  • Non-attendance at the first intervention appointment after three scheduling attempts
  • Chronic use of systemic
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Corticosteroids (steroids)

Anti-inflammatory medicines such as prednisone, prednisolone and dexamethasone — not the anabolic steroids used for muscle.

Studies differ in what they allow: check which steroid medicines, routes (tablets, injections, creams, inhalers, eye drops) and doses this study accepts.

05

Study design

Phase
Phase 4
Primary purpose
Treatment
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
152 participants (estimated)

Study arms

  • Experimental
    Sedation

    The child receives sedatives approved for use in an outpatient setting, directed by a doctor, to accomplish the dental treatment.

    Drug: Ketamine 50 MG/ML · Drug: Midazolam Hcl 2Mg/Ml Syrup

  • Other
    Control

    The child does not receive sedatives. As s/he exhibits negative behavior for the dental procedure, s/he will be restrained by a family member and dental team.

    Procedure: Protective stabilization

Interventions

  • DrugKetamine 50 MG/ML

    Drug page: KetamineStudies of KetamineKetamine pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Ketamine injectable solution in a concentration of 50.0 mg/mL via oral route; dose of 4.0 mg/kg maximum 100.0 mg

    Also known as: Ketamin S, Cristalia, São Paulo, Brazil

  • DrugMidazolam Hcl 2Mg/Ml Syrup

    Drug page: MidazolamStudies of MidazolamMidazolam pageHow we knowJudged by ClinicalTrials.gg, not part of the registry record.

    Midazolam oral solution in a concentration of 2.0 mg/mL via oral route; dose of 0.5 mg/kg, maximum 5.0 mg when associated with ketamine;

    Also known as: Dormire oral solution, Cristalia, Sao Paulo, Brazil

  • ProcedureProtective stabilization

    The legal guardian or accompanying person appointed by the legal guardian should sit in the dental chair with the child and contain leg and arm movements. A dental assistant keeps the child's head contained during care.

06

What researchers measure

Primary outcomes

  1. Child behavior during the dental treatment

    Children's behavior assessed by OSUBRS (Ohio State University Behavioral Rating Scale) in digital videos recorded during the administration. Scores: 1 - quiet, 2 - cry with movement, 3 - movement without cry; 4 - struggling. The higher the percentage of time of care in which the child behaves quietly, the better their behavior. Measurements for each group will be synthesized as mean (or median) and standard deviation (or interquartile range).

    Time frame: Participants will be followed for the duration of the dental session, an expected average of 40 minutes

Secondary outcomes

  1. Progression of child behavior throughout the follow-up

    A 10-centimeter Visual Analogue Scale (VAS) is used by one of the trained/calibrated dentists to measure the child behavior during the dental session (Hosey and Blinkhorn, 2005). The VAS anchors are "negative behavior" (left) and "positive behavior" (right). At the end of the session, raters mark a point on the 10 cm line to correspond to the perceived level of behavior; this is then measured using a ruler to give a score to the nearest millimeter which can vary from 0 to 100). The higher the VAS score, the better the child's behavior assessed by the dentist

    Time frame: Baseline (dental examination) plus follow-up sessions at 4, 8, and 12 months post-treatment

  2. Progression of child dental anxiety throughout the follow-up

    Facial Image Scale (Buchanan and Niven, 2002), a row of five faces ranging from "very happy" to "very sad," and numbered from 1 (very happy, most positive response) to 5 (very sad, the most negative).

    Time frame: Baseline (dental examination) plus follow-up sessions at 4, 8, and 12 months post-treatment

  3. Impact on oral health-related quality of life and changes after treatment

    The B-ECOHIS is a measure of oral health-related quality of life (OHRQoL) validated in Brazil by Scarpelli et al. (2008) to assess the impact of oral health problems and related treatment on the quality of life of children aged zero to five years and their families. "The ECOHIS consists of 13 questions divided into two main parts: child impact section (part one) and family impact section (part two). The child impact section comprises of four subscales: child symptom, child function, child psychology and child self-image/social interaction. The family impact section contains two subscales: parental distress and family function. The questionnaire is scored using a simple five-point Likert scale with responses ranging from "never" to "very often" (equivalent to a score of 0 and 4, respectively). A total score ranging from zero to 52 is calculated as a simple sum of the responses with higher scores denoting a greater oral health impact and/or poorer OHRQoL." (Martins-Junior et a. 2012).

    Time frame: Baseline (dental examination) plus follow-up sessions at 4, 8, and 12 months post-treatment

  4. Parental satisfaction with the intervention

    A 10-centimeter Visual Analogue Scale (VAS) is used by the accompanying adult to measure her/his satisfaction with the child's dental session. The VAS anchors are "no satisfaction" (left) and "extreme satisfaction" (right). At the end of the session, raters mark a point on the 10 cm line to correspond to their level of satisfaction; this is then measured using a ruler to give a score to the nearest millimeter, which can vary from 0 to 100. The higher the VAS score, the greater the respondent satisfaction

    Time frame: At the end of each session from dental examination through the end of the dental treatment, an average of 2 months

  5. Parental stress (anxiety) with the intervention

    A 10-centimeter Visual Analogue Scale (VAS) is used by the accompanying adult to measure her/his perceived stress (anxiety) with the child's dental session. The VAS anchors are "relaxed" (left) and "too nervous" (right). At the end of the session, raters mark a point on the 10 cm line to correspond to their level of stress (anxiety); this is then measured using a ruler to give a score to the nearest millimeter, which can vary from 0 to 100. The higher the VAS score, the greater the respondent stress

    Time frame: At the end of each session from dental examination through the end of the dental treatment, an average of 2 months

  6. Dentist's satisfaction with the intervention

    A 10-centimeter Visual Analogue Scale (VAS) is used by the dentist in charge to measure her/his satisfaction with the child's dental session. The VAS anchors are "no satisfaction" (left) and "extreme satisfaction" (right). At the end of the session, raters mark a point on the 10 cm line to correspond to their level of satisfaction; this is then measured using a ruler to give a score to the nearest millimeter, which can vary from 0 to 100. The higher the VAS score, the greater the respondent satisfaction

    Time frame: At the end of each session from dental examination through the end of the dental treatment, an average of 2 months

  7. Dentist's stress (anxiety) with the intervention

    A 10-centimeter Visual Analogue Scale (VAS) is used by the dentist in charge to measure her/his perceived stress (anxiety) with the child's dental session. The VAS anchors are "relaxed" (left) and "too nervous" (right). At the end of the session, raters mark a point on the 10 cm line to correspond to their level of stress (anxiety); this is then measured using a ruler to give a score to the nearest millimeter, which can vary from 0 to 100. The higher the VAS score, the greater the respondent stress

    Time frame: At the end of each session from dental examination through the end of the dental treatment, an average of 2 months

  8. Child pain reported by the parent

    A 10-centimeter Visual Analogue Scale (VAS) is used by the accompanying child to measure her/his perceived pain in the child undergoing dental treatment. The VAS anchors are "no pain" (left) and "too much pain" (right). At the end of the session, raters mark a point on the 10 cm line to correspond to the perceived level of child's pain; this is then measured using a ruler to give a score to the nearest millimeter, which can vary from 0 to 100. The higher the VAS score, the greater the child's pain according to the parent

    Time frame: At the end of each session from dental examination through the end of the dental treatment, an average of 2 months

  9. Child pain reported by the dentist

    A 10-centimeter Visual Analogue Scale (VAS) is used by the dentist in charge to measure her/his perceived pain in the child undergoing dental treatment. The VAS anchors are "no pain" (left) and "too much pain" (right). At the end of the session, raters mark a point on the 10 cm line to correspond to the perceived level of child's pain; this is then measured using a ruler to give a score to the nearest millimeter, which can vary from 0 to 100. The higher the VAS score, the greater the child's pain according to the dentist

    Time frame: At the end of each session from dental examination through the end of the dental treatment, an average of 2 months

  10. Child pain/distress during the dental restoration session

    FLACC Pain Assessment Tool (Faces, Legs, Activity, Cry and Consolability) scored by trained and calibrated observers after watching the videos of the dental treatment. The FLACC is a measurement used to assess pain for children between the ages of 2 months and 7 years. The scale is scored in a range of 0-10 with 0 representing no pain and 10, too much pain. The scale has five criteria, which are each assigned a score of 0, 1 or 2: face, legs, activity, cry and consolability (Merkel et al., 1997).

    Time frame: Duration of the dental session, an expected average of 40 minutes

  11. Adverse events during the dental procedure

    Occurrence of adverse events assessed by the Tracking and Reporting Outcomes of Procedural Sedation (TROOPS) (Roback et al. 2018) in the Moderate Sedation Group, or occurrence of bruises or inconsolability in the protective stabilization group

    Time frame: Participants will be followed for the duration of the dental session, an expected average of 40 minutes. Sedated patients will also be followed in the recovery room, an expected average of 60 minutes

  12. Number of teeth restored

    Restored teeth count at the end of each session

    Time frame: End of each session of dental treatment, an average of 2 months

  13. Longevity of composite resin and glass ionomer cement restorations

    Trained and calibrated observers will follow the criteria for assessing occlusal (Frencken and Holmgren 2001) or occlusal-proximal (Roeleveld et al. 2006) restorations to categorize each restoration as successful or failed

    Time frame: At a time point of 5 minutes (average) after the end of the dental procedure, and in the follow-up sessions (4, 8 and 12 months)

  14. Children's stress according to salivary cortisol

    Occurrence of stress during dental procedure, assessed by salivary cortisol in children; the ELISA test will determine changes in cortisol level during dental treatment

    Time frame: Change from baseline in the salivary cortisol at an expected average of 40 minutes

  15. Cost analysis

    Cost-efficacy of different sedation protocols according to the methodology of health technologies assessment; the cost of each intervention will be compared

    Time frame: An expected average of 15 months

07

Study locations

1 of 2 sites recruiting
  • Dental School - UFG
    Goiania, Goias 74605220, Brazil
    Active, not recruiting

    Not enrolling at this site.

  • Dental School - FOUSP
    São Paulo, SP 05508-000, Brazil
    Recruiting
    • Daniela P Raggio, PhD · Contactdanielar@usp.br · +55 (11) 30917812
    • Daniela P Raggio, PhD · Principal investigator
08

References and documents

Publications

  • da Silva GS, Anabuki AA, Viana KA, Correa-Faria P, Moterane MM, Tedesco TK, Costa PS, Hosey MT, Raggio DP, Costa LR; CEDACORE Collaborative Group. Sedation versus protective stabilization for dental treatment of children with caries and challenging behavior at the dentist (CHOOSE): a study protocol for a non-randomized clinical trial. BMC Oral Health. 2021 May 12;21(1):256. doi: 10.1186/s12903-021-01594-0. PubMed 33980232 ↗

Individual participant data

Plan to share: Yes — All IPD that underlie results in a publication

Supporting information: Study protocol, Informed consent form

Time frame: 2023 to 2024

Access criteria: According to the digital platform rules.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Jan 2020 (actual). Primary completion is estimated for Feb 2025, 60 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 1, 2019
First posted
Oct 8, 2019
StartActual
Jan 30, 2020
Primary completionEst.
Feb 28, 2025
CompletionEst.
Feb 28, 2026
Last update
Dec 10, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 10, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04119180
Lead sponsor
Universidade Federal de Goias
Responsible party
Luciane Ribeiro de Rezende Sucasas da Costa (Professor, Universidade Federal de Goias) — Principal investigator
First posted
Oct 8, 2019
Start date
Jan 30, 2020
Primary completion
Feb 28, 2025 (estimated)
Completion
Feb 28, 2026 (estimated)
Last update
Dec 10, 2024

Study contacts

Patricia C Faria, PhD
Contact
patriciacorreafaria@ufg.br
6232096325
Luciane R Costa, PhD
Contact
lsucasas@ufg.br
+556232096325
Luciane RS Costa, PhD
principal investigator · Universidade Federal de Goias
Daniela P Raggio, PhD
study director · University of Sao Paulo
Patricia C Faria, PhD
principal investigator · Universidade Federal de Goias

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Studies of the drugs tested here: Ketamine · Midazolam

Start the discussion